| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 4 |
| 1 | GABAPENTIN | 4 |
| 2 | PEMBROLIZUMAB | 3 |
| 3 | SPARSENTAN | 3 |
| 4 | ACETAMINOPHEN | 2 |
| 5 | ACETAMINOPHEN 500MG | 2 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 7 | AMLODIPINE | 2 |
| 8 | ASPIRIN | 2 |
| 9 | ASPIRIN 325 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPTACOPAN | 1 | 0.0013 |
| 1 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | SPARSENTAN | 3 | 0.0004 |
| 4 | PENICILLIN G | 1 | 0.0004 |
| 5 | PHENAZOPYRIDINE | 1 | 0.0003 |
| 6 | BETAMETHASONE VALERATE FOAM | 1 | 0.0002 |
| 7 | TEPROTUMUMAB | 1 | 0.0002 |
| 8 | AVACOPAN | 1 | 0.0001 |
| 9 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Alkaloid [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |